Certified by Founder Lodge
Wellington Management
United States - Boston, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $238,000,000
71 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
-
Website
https://www.wellington.com/en/about-us/why-wellington-management
- Contact
- Social Links
For almost 100 years, we have chosen to do things differently, including the way we structure our ownership model, organization, and investment platform. Critically, we know that the best inv
| Company | Date | Round | Raised |
|---|---|---|---|
 CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
 HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
 SeatGeek |
September, 01 ,2022 | Series E | $238,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 SPAN |
March, 22 ,2022 | Series B | $90,000,000 |
 FalconX |
June, 22 ,2022 | Series D | $150,000,000 |
 Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
 Arcadia |
May, 10 ,2022 | Series E | $200,000,000 |
 Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
 Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Xepelin |
May, 05 ,2022 | Series B | $111,000,000 |
 AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
 Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| SPAN |
March, 22 ,2022 | Series B | $90,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
| Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
 AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
 GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Mindset |
August, 21 ,2024 | Unknown | $1,300,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
 Trace Machina |
August, 23 ,2024 | Seed | $4,700,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
 Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Mindset |
August, 21 ,2024 | Unknown | $1,300,000 |
| Trace Machina |
August, 23 ,2024 | Seed | $4,700,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
 Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
 Quince |
January, 29 ,2025 | Series C | $120,000,000 |
 Tubulis GmbH |
October, 16 ,2025 | Series C | $359,197,300 |
dezerv.
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
